{"disease":{"id":"progressive-supranuclear-palsy-psp","name":"progressive supranuclear palsy psp"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04363684","title":"ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)","phase":"","overall_status":"RECRUITING","enrollment_count":2100,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06949865","title":"AI-Enhanced Optimization of Acute Levodopa Challenge Test","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT06647641","title":"The CurePSP Genetics Program","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04715399","title":"UPenn Observational Research Repository on Neurodegenerative Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT03030586","title":"ADDIA Proof-of-Performance Clinical Study","phase":"","overall_status":"COMPLETED","enrollment_count":821,"lead_sponsor_name":"Amoneta Diagnostics SAS","has_results":false},{"nct_id":"NCT07392411","title":"Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers","phase":"","overall_status":"RECRUITING","enrollment_count":720,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT07141719","title":"Collection of Digital Parameters From Parts of the Neurological Examination Using an Eye Tracker","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"University of Kiel","has_results":false},{"nct_id":"NCT07173803","title":"The Progressive Supranuclear Palsy Clinical Trial Platform","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":440,"lead_sponsor_name":"Adam Boxer","has_results":false},{"nct_id":"NCT07498426","title":"A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04193527","title":"A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"GE Healthcare","has_results":true},{"nct_id":"NCT03391765","title":"An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":142,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT06122662","title":"AMX0035 and Progressive Supranuclear Palsy","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Amylyx Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT02839642","title":"Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT07240805","title":"Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"BioSensics","has_results":false},{"nct_id":"NCT04539041","title":"Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06597071","title":"Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":40,"lead_sponsor_name":"NeuraLight","has_results":false},{"nct_id":"NCT05121012","title":"Synaptic Loss in Multiple System Atrophy","phase":"","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"University of Exeter","has_results":false},{"nct_id":"NCT03545126","title":"Human CNS Tau Kinetics in Tauopathies","phase":"","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT03413319","title":"Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"AbbVie","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}